Synvista Therapeutics, Inc. (AMEX: SYI) announced that, following a review of its clinical development portfolio and its current financial status ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE